9.4. The role of the gamma knife in the management of cerebral astrocytomas

Progress in Neurological Surgery

Volumn 20, Issue , 2007, Pages 150-163

  Szeifert, G ^a   Prasad, D ^b   Kamyrio, T ^b   Steiner, M ^b   Steiner, L ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTROCYTOMA; BRACHYTHERAPY; BRAIN TUMOR; CANCER STAGING; HUMAN; METHODOLOGY; MORTALITY; PATHOLOGY; PROGNOSIS; RADIATION DOSE; RADIOSURGERY; RETROSPECTIVE STUDY; SURVIVAL; TIME; TREATMENT OUTCOME;

ASTROCYTOMA; BRACHYTHERAPY; BRAIN NEOPLASMS; HUMANS; NEOPLASM STAGING; PROGNOSIS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34447529105     PISSN: 00796492     EISSN: 16623924     Source Type: Book Series    
DOI: 10.1159/000100102     Document Type: Article

References (31)

1. Levin VA, Gutin PH, Leibel S: Neoplasms of the central nervous system; in De Vita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. Philadelphia, Lippincott Williams & Wilkins, 1993, pp 1679-1737.
2. Shrieve DC, Gutin PH, Larson DA: Brachytherapy; in Mauch P, Loeffler JS (eds): Radiation Oncology, Technology and Biology. Philadelphia, WB Saunders, 1994, pp 216-236.
3. Brem H, Piantadosi S, Burger PC, et al: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer Brain Tumor Treatment Group. Lancet 1995;345:1008-1012.
4. Sipos L, Wakabayashi T, Szeifert GT, et al: Characterization of human gliomas by a monoclonal antibody both on tissue culture and paraffin-embedded sections. Neurol Res 1992;14:263-266.
5. Kramm CM, Sena-Esteves M, Barnett FH, et al: Gene therapy for brain tumors. Brain Pathol 1995;5:345-381.
6. Salcman M: Survival in glioblastoma: Historical perspective. Neurosurgery 1980;7:435-439.
7. Salford LG, Brun A, Nirfalk S: Ten-year survival among patients with supratentorial astrocytomas grade III and IV. J Neurosurg 1988;69:506-509.
8. Walker MD, Strike TA, Sheline GE: An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979;5:1725-1731.
9. Bleehen NM, Stenning SP: A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumor Working Party. Br J Cancer 1991;64:769-774.
10. Scharfen CO, Sneed PK, Wara WM, et al: High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 1992;24:583-591.
11. Wen PY, Alexander E 3rd, Black PM, et al: Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas. Cancer 1994;73:3029-3036.
12. Curran W, Scott C, Weinstein A, et al: Survival comparision of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and Carmustine; A report of Radiation Therapy Oncology Group 83-02. J Clin Oncol 1993;11:857-862.
13. Simpson JR, Horton J, Scott C, et al: Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 1993;26:239-244.
14. Philippon JH, Clemenceau SH, Fauchon FH, et al: Supratentorial low-grade astrocytomas in adults. Neurosurgery 1993;32:554-559.
15. North CA, North RB, Epstein JA, et al: Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy. Cancer 1990;66:6-14.
16. Shaw EG, Scheithauer BW, O'Fallon JR: Management of supratentorial low-grade gliomas. Oncology 1993;7:97-111.
17. Lunsford LD, Somaza S, Kondziolka D, et al: Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma. J Neurosurg 1995;82:523-529.
18. Walker MD, Green SB, Byar DP, et al: Randomized comparison of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980;303:1323-1329.
19. Mundinger F, Braus DF, Krauss JK, et al: Long-term outcome of 89 low-grade brain-stem gliomas after interstitial radiation therapy. J Neurosurg 1991;75:740-746.
20. Voges J, Treuer H, Schlegel W, et al: Interstitial irradiation of cerebral gliomas with stereotactically implanted iodine-125 seeds. Acta Neurochir 1993;58(SUPPL):108-111.
21. Scharfen CO, Sneed PK, Wara WM, et al: High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 1992;24:583-591.
22. Viola A, Major T, Julow J: The importance of postoperative CT image fusion verification of stereotactic interstitial irradiation for brain tumors. Int J Radiat Oncol Biol Phys 2004;60:322-328.
23. Colombo F: Linear accelerator radiosurgery. A clinical experience. J Neurosurg Sci 1989;33: 123-125.
24. Barcia JA, Barcia-Salorio JL, Ferrer C, et al: Stereotactic radiosurgery of deeply seated low grade gliomas. Acta Neurochir 1994;62(SUPPL):58-61.
25. Grabb PA, Lunsford LD, Albright AL, et al: Stereotactic radiosurgery for glial neoplasms of childhood. Neurosurgery 1996;38:696-701.
26. Masciopinto JE, Levin AB, Mehta MP, et al: Stereotactic radiosurgery for glioblastoma: A final report of 31 patients. J Neurosurg 1995;82:530-535.
27. Sarkaria JN, Mehta MP, Loeffler JS, et al: Radiosurgery in the initial management of malignant gliomas: Survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1995;32:931-941.
28. Larson DA, Gutin PH, McDermott M, et al: Gamma Knife for glioma: Selection factors and survival. Int J Radiat Oncol Biol Phys 1996;36:1045-1053.
29. Kondziolka D, Flickinger JC, Bissonette DJ, et al: Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 1997;41:776-783.
30. Barker FG 2nd, Prados MD, Chang SM, et al: Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg 1996;84:442-448.
31. Levivier M, Wikler d, Goldman S, et al: Integration of metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the gamma knife: Early experience with brain tumors. J Neurosurg 2000;93(SUPPL3):233-238.